Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TCM-Shanghai University of Traditional Chinese Medicine-non-small cell lung cancer
- Development stage
- Unknown
- Lead developer
- Shanghai University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
TCM-Shanghai University of Traditional Chinese Medicine-non-small cell lung cancer refers to a comprehensive rehabilitation program developed for patients with postoperative stage IB-IIIA non-small cell lung cancer (NSCLC). The program integrates staged Traditional Chinese Medicine (TCM) herbal granules—specifically formulated to 'supplement Qi,' 'nourish Yin,' 'harmonize the stomach,' and 'detoxify'—with Liu Zi Jue (LZJ) breathing exercises and rehabilitation education. This multi-modal intervention is administered as an adjuvant to standard platinum-based chemotherapy. It is designed to improve the quality of life, reduce chemotherapy-related toxicities, and potentially enhance disease-free and long-term survival. The program has been evaluated in a multicenter, randomized, placebo-controlled trial (NCT03372694) involving several hospitals in Shanghai.
- Other names
- Comprehensive Rehabilitation ProgramStaged Chinese herbal medicine therapyCHM therapyLiu Zi Jue breathing exercises
Beyond the preview
Go deeper on TCM-Shanghai University of Traditional Chinese Medicine-non-small cell lung cancer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TCM-Shanghai University of Traditional Chinese Medicine-non-small cell lung cancer.